Anterix (ATEX) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Anterix (ATEX) over the last 12 years, with Q1 2025 value amounting to $1.6 million.

  • Anterix's Accumulated Expenses fell 944.48% to $1.6 million in Q1 2025 from the same period last year, while for Mar 2025 it was $1.6 million, marking a year-over-year decrease of 944.48%. This contributed to the annual value of $1.6 million for FY2025, which is 944.48% down from last year.
  • Latest data reveals that Anterix reported Accumulated Expenses of $1.6 million as of Q1 2025, which was down 944.48% from $1.7 million recorded in Q1 2024.
  • Over the past 5 years, Anterix's Accumulated Expenses peaked at $1.7 million during Q1 2024, and registered a low of $735000.0 during Q1 2022.
  • Moreover, its 5-year median value for Accumulated Expenses was $1.3 million (2023), whereas its average is $1.3 million.
  • As far as peak fluctuations go, Anterix's Accumulated Expenses crashed by 6846.82% in 2021, and later soared by 7238.1% in 2023.
  • Over the past 5 years, Anterix's Accumulated Expenses (Quarter) stood at $951000.0 in 2021, then fell by 22.71% to $735000.0 in 2022, then soared by 72.38% to $1.3 million in 2023, then skyrocketed by 37.88% to $1.7 million in 2024, then fell by 9.44% to $1.6 million in 2025.
  • Its last three reported values are $1.6 million in Q1 2025, $1.7 million for Q1 2024, and $1.3 million during Q1 2023.